logo-loader
viewArcadia Biosciences Inc

Arcadia Biosciences reports 1Q highlights and outlines growth drivers for 2019

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive Investors the California-based company is looking forward to a number of milestones ahead for its product lines.

Ketkar says the company is rapidly advancing its cannabis business, while also pushing forward the first sales of its GoodWheat product and HB4 drought-tolerant soybeans.

Quick facts: Arcadia Biosciences Inc

Price: 5.3 USD

NASDAQ:RKDA
Market: NASDAQ
Market Cap: $45.82 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arcadia Biosciences Inc named herein, including the promotion by the Company of Arcadia Biosciences Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences debuts new GoodHemp product line,...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Matt Plavan tells Proactive the California-based company has launched a new product line called GoodHemp. Plavan says GoodHemp is the company's new hemp seed, transplants, flower and extracts brand, and its first commercial product is a...

23 hours, 18 minutes ago

2 min read